Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries

Video   Sep 19, 2016

 

Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.

 
Company Information

Request Information

 
 
 

Recommended Videos

Cancer Revealed: How the Immune System Sees and Destroys Tumors

Video

Jeffrey S. Weber, M.D., Ph.D., discusses the cancer immunity cycle and the importance of antigen release and presentation to maximize the potential of immunotherapies.

WATCH NOW

Eating for Two Trillion: Dietary Intake Shapes Our Resident Gut Microbes

Video

Humans are each home to trillions of microbes that have a widespread impact on our physiology and predisposition to disease. Peter Turnbaugh, PhD, Assistant Professor, Department of Microbiology and Immunology, UCSF, explains.

WATCH NOW

Biologic Agents: Treatment of Autoimmune Diseases

Video

Dr. Andrew Gross, UCSF Rheumatology Clinic Director, explores the latest strategies in the treatment of autoimmune diseases.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE